CD40LG and Respiratory tract infection: Therefore, this study aimed to provide a long-term comparison by using an externally controlled design to compare the effects of leniolisib on the rate of respiratory tract infections and on serum IgM levels versus the current standard of care with symptomatic treatments in patients with APDS.